InvestSMART

Lumos Diagnostics Holdings Limited (ASX:LDX)

ALERT: Price-sensitive ASX Announcement for LDX
Current share price for LDX : $0.084 -0.016 (-16%)+
Announcement
Release
26 Aug 2026 9:22AM
Price at Release
$0.100
Full Release
download
Summary
Lumos Diagnostics Holdings Limited released its Appendix 4E preliminary final report for the fiscal year ending June 30, 2026. The company reported an increase in revenues from ordinary activities by 6.4% to US$13,192,000. However, it also reported a loss from ordinary activities after tax of US$4.95 million, which is a 31.1% decrease compared to the previous year’s loss of US$7.18 million. There were no dividends declared or paid during the period. The net tangible assets per ordinary security improved from a negative 0.14 US cents to 0.01 US cents. The financial statements were audited and received an unmodified opinion, though a material uncertainty was noted regarding the company's ability to continue as a going concern.
Key Points
  • Revenues from ordinary activities increased by 6.4% to US$13,192,000.
  • Loss from ordinary activities after tax decreased by 31.1% to US$4.95 million.
  • No dividends were paid or declared during the financial period.
  • Net tangible assets per security improved to 0.01 US cents from negative 0.14 US cents.
  • Audit report notes material uncertainty over going concern status.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.